Clifton Medispa Limited 08596703 false 2025-06-01 2026-05-31 2026-05-31 The principal activity of the company is provision of chiropody and other health and cosmetic treatments Digita Accounts Production Advanced 6.30.9574.0 true 08596703 2025-06-01 2026-05-31 08596703 2026-05-31 08596703 core:RetainedEarningsAccumulatedLosses 2026-05-31 08596703 core:ShareCapital 2026-05-31 08596703 core:CurrentFinancialInstruments 2026-05-31 08596703 core:CurrentFinancialInstruments core:WithinOneYear 2026-05-31 08596703 core:OfficeEquipment 2026-05-31 08596703 bus:SmallEntities 2025-06-01 2026-05-31 08596703 bus:AuditExemptWithAccountantsReport 2025-06-01 2026-05-31 08596703 bus:FilletedAccounts 2025-06-01 2026-05-31 08596703 bus:SmallCompaniesRegimeForAccounts 2025-06-01 2026-05-31 08596703 bus:RegisteredOffice 2025-06-01 2026-05-31 08596703 bus:Director1 2025-06-01 2026-05-31 08596703 bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 08596703 bus:Agent1 2025-06-01 2026-05-31 08596703 core:Goodwill 2025-06-01 2026-05-31 08596703 core:OfficeEquipment 2025-06-01 2026-05-31 08596703 countries:EnglandWales 2025-06-01 2026-05-31 08596703 2025-05-31 08596703 core:OfficeEquipment 2025-05-31 08596703 2024-06-01 2025-05-31 08596703 2025-05-31 08596703 core:RetainedEarningsAccumulatedLosses 2025-05-31 08596703 core:ShareCapital 2025-05-31 08596703 core:CurrentFinancialInstruments 2025-05-31 08596703 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 08596703 core:OfficeEquipment 2025-05-31 iso4217:GBP xbrli:pure

Registration number: 08596703

Clifton Medispa Limited
Unaudited Filleted Abridged Financial Statements
for the Year Ended 31 May 2026

Clifton Medispa Limited

Contents

Accountants' Report | 1
Abridged Balance Sheet | 2
Notes to the Unaudited Abridged Financial Statements | 3 to 5

Chartered Certified Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Clifton Medispa Limited
for the Year Ended 31 May 2026

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Clifton Medispa Limited for the year ended 31 May 2026 as set out on pages 2 to 5 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/gb/en/member/standards/rules-and-standards/rulebook.html.

This report is made solely to the Board of Directors of Clifton Medispa Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Clifton Medispa Limited and state those matters that we have agreed to state to the Board of Directors of Clifton Medispa Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/gb/en/technical-activities/technical-resources-search/2009/
october/factsheet-163-audit-exempt-companies.html. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Clifton Medispa Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Clifton Medispa Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Clifton Medispa Limited. You consider that Clifton Medispa Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Clifton Medispa Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
Jay & Jay Partnership Limited
Chartered Certified Accountants
2 Chesterfield Buildings
Westbourne Place
Clifton Bristol
BS8 1RU

1 July 2026

Clifton Medispa Limited

(Registration number: 08596703)
Abridged Balance Sheet as at 31 May 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Tangible assets | 5 | 7,012 | 4,181
Current assets |  |  |
Debtors |  | 684 | 828
Cash at bank and in hand |  | 20,151 | 16,294
|  | 20,835 | 17,122
Creditors: Amounts falling due within one year |  | 11,205 | 11,189
Net current assets |  | 9,630 | 5,933
Net assets |  | 16,642 | 10,114
Capital and reserves |  |  |
Called up share capital |  | 2 | 2
Retained earnings |  | 16,640 | 10,112
Shareholders' funds |  | 16,642 | 10,114

For the financial year ending 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 June 2026 and signed on its behalf by:

......................................... Mr E. W. Jones Director

Clifton Medispa Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2026

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Chesterfield Buildings
Westbourne Place
Clifton Bristol
BS8 1RU

These financial statements were authorised for issue by the Board on 30 June 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Clifton Medispa Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2026

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Equipment | 15% Reducing Balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Goodwill | 5% Straight Line

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities, or equity instruments. An equity instrument is any contact that evidences a residual interest in the assets of the company after deducting all of its liabilities.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

Clifton Medispa Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 May 2026

4 | Intangible assets

| Total £
Cost or valuation
At 1 June 2025 | 8,500
At 31 May 2026 | 8,500
Amortisation
At 1 June 2025 | 8,500
At 31 May 2026 | 8,500
Carrying amount
At 31 May 2026 | -

5 | Tangible assets

| Office equipment £ | Total £
Cost or valuation
At 1 June 2025 | 11,007 | 11,007
Additions | 4,068 | 4,068
At 31 May 2026 | 15,075 | 15,075
Depreciation
At 1 June 2025 | 6,826 | 6,826
Charge for the year | 1,237 | 1,237
At 31 May 2026 | 8,063 | 8,063
Carrying amount
At 31 May 2026 | 7,012 | 7,012
At 31 May 2025 | 4,181 | 4,181

6 | Related party transactions

Other transactions with directors

At 31st May 2026 the company owed the directors £354 (2025 - £180). This loan is interest free and repayable on demand.
During the year the company loaned funds to the directors which were fully by 31st May 2026. Interest was charged on the amount overdrawn at HMRC's prescribed rate of 3.75% totalling £373. The maximum amount overdrawn was £23,286.